{"id":4277,"date":"2020-12-24T22:09:46","date_gmt":"2020-12-24T19:09:46","guid":{"rendered":"http:\/\/www.alfapatent-stanadvoka.com\/?page_id=4277"},"modified":"2021-01-11T22:54:41","modified_gmt":"2021-01-11T19:54:41","slug":"farmasotik-sahada-patentler","status":"publish","type":"page","link":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/farmasotik-sahada-patentler\/","title":{"rendered":"Farmas\u00f6tik Sahada Patentler"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;1\/4&#8243; offset=&#8221;vc_hidden-md vc_hidden-sm vc_hidden-xs&#8221; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243; woodmart_sticky_column=&#8221;false&#8221; parallax_scroll=&#8221;no&#8221; mobile_reset_margin=&#8221;no&#8221; tablet_reset_margin=&#8221;no&#8221;]\n\t\t\t<div id=\"wd-5fe4b520602b0\" class=\"widget_nav_mega_menu shortcode-mega-menu \">\n\n\t\t\t\t\n\t\t\t\t<div class=\"woodmart-navigation vertical-navigation\">\n\t\t\t\t\t<div class=\"menu-1-left-menu-turkish-container\"><ul id=\"menu-1-left-menu-turkish\" class=\"menu\"><li id=\"menu-item-4333\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-4333 item-level-0 menu-item-design-default menu-simple-dropdown item-event-hover\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/patent-ve-faydali-model-basvurulari\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Patent Ve Faydal\u0131 Model Ba\u015fvurular\u0131<\/span><\/a>\n<div class=\"sub-menu-dropdown color-scheme-\">\n\n<div class=\"container\">\n\n<ul class=\"sub-menu color-scheme-\">\n\t<li id=\"menu-item-4334\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4334 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/teknik-gelistirmelerin-korunma-bicimleri\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Teknik Geli\u015ftirmelerin Korunma Bi\u00e7imleri<\/span><\/a><\/li>\n\t<li id=\"menu-item-4335\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4335 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/turk-patent-marka-kurumu-temsil-yetkisi\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">T\u00fcrk Patent Marka Kurumu Temsil Yetkisi<\/span><\/a><\/li>\n\t<li id=\"menu-item-4336\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4336 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/turk-patent-basvurulari\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">T\u00fcrk Patent Ba\u015fvurular\u0131<\/span><\/a><\/li>\n\t<li id=\"menu-item-4337\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4337 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/faydali-model-basvurusu\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Faydal\u0131 Model Ba\u015fvurusu<\/span><\/a><\/li>\n\t<li id=\"menu-item-4338\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4338 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/uluslararasi-patent-basvurularinin-yerel-evre-girisleri\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Uluslararas\u0131 Patent Ba\u015fvurular\u0131n\u0131n Yerel Evre Giri\u015fleri<\/span><\/a><\/li>\n\t<li id=\"menu-item-4339\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4339 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patent-tescili\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patent Tescili<\/span><\/a><\/li>\n\t<li id=\"menu-item-4340\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4340 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/farmasotik-sahada-patentler\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Farmas\u00f6tik Sahada Patentler<\/span><\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/li>\n<li id=\"menu-item-4341\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-4341 item-level-0 menu-item-design-default menu-simple-dropdown item-event-hover\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/ulusal-hukukta-asli-ve-prosedurel-hususlar\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Ulusal Hukukta Asli Ve Prosed\u00fcrel Hususlar<\/span><\/a>\n<div class=\"sub-menu-dropdown color-scheme-\">\n\n<div class=\"container\">\n\n<ul class=\"sub-menu color-scheme-\">\n\t<li id=\"menu-item-4342\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4342 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/patentlenebilirlik-sartlari\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Patentlenebilirlik \u015eartlar\u0131<\/span><\/a><\/li>\n\t<li id=\"menu-item-4343\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4343 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/turk-patent-basvurusu-belgeler-ve-ceviri-gerekleri\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">T\u00fcrk Patent Ba\u015fvurusu Belgeler Ve \u00c7eviri Gerekleri<\/span><\/a><\/li>\n\t<li id=\"menu-item-4344\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4344 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/hukumsuzluk-ve-tecavuz-ihtilaflari\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">H\u00fck\u00fcms\u00fczl\u00fck Ve Tecav\u00fcz \u0130htilaflar\u0131<\/span><\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/li>\n<li id=\"menu-item-4345\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-4345 item-level-0 menu-item-design-default menu-simple-dropdown item-event-hover\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patent-basvurulari\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patent Ba\u015fvurular\u0131<\/span><\/a>\n<div class=\"sub-menu-dropdown color-scheme-\">\n\n<div class=\"container\">\n\n<ul class=\"sub-menu color-scheme-\">\n\t<li id=\"menu-item-4346\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4346 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patent-ofisi-nezdinde-temsil\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patent Ofisi Nezdinde Temsil<\/span><\/a><\/li>\n\t<li id=\"menu-item-4347\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4347 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patent-basvurulari-sureci\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patent Ba\u015fvurular\u0131 S\u00fcreci<\/span><\/a><\/li>\n\t<li id=\"menu-item-4348\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4348 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patent-basvurusu-on-koruma\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patent Ba\u015fvurusu \u00d6n Koruma<\/span><\/a><\/li>\n\t<li id=\"menu-item-4349\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4349 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/ucuncu-kisi-gorusu\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">\u00dc\u00e7\u00fcnc\u00fc Ki\u015fi G\u00f6r\u00fc\u015f\u00fc<\/span><\/a><\/li>\n\t<li id=\"menu-item-4350\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4350 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patent-tescili\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patent Tescili<\/span><\/a><\/li>\n\t<li id=\"menu-item-4351\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4351 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patentlerine-itiraz\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patentlerine \u0130tiraz<\/span><\/a><\/li>\n\t<li id=\"menu-item-4352\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4352 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/avrupa-patent-ofisi-kararlarinin-temyizi\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Avrupa Patent Ofisi Kararlar\u0131n\u0131n Temyizi<\/span><\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/li>\n<li id=\"menu-item-4353\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-4353 item-level-0 menu-item-design-default menu-simple-dropdown item-event-hover\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/pct-ve-uluslararasi-basvuru-sistemi\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Pct Ve Uluslararas\u0131 Ba\u015fvuru Sistemi<\/span><\/a>\n<div class=\"sub-menu-dropdown color-scheme-\">\n\n<div class=\"container\">\n\n<ul class=\"sub-menu color-scheme-\">\n\t<li id=\"menu-item-4354\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4354 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/uluslararasi-patent-basvurusu-temel-bilgiler\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Uluslararas\u0131 Patent Ba\u015fvurusu Temel Bilgiler<\/span><\/a><\/li>\n\t<li id=\"menu-item-4355\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4355 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/dunya-fikri-haklar-teskilati-nezdinde-temsil\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">D\u00fcnya Fikri Haklar Te\u015fkilat\u0131 Nezdinde Temsil<\/span><\/a><\/li>\n\t<li id=\"menu-item-4356\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4356 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/pct-altinda-ucuncu-kisi-gorusu\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Pct Alt\u0131nda \u00dc\u00e7\u00fcnc\u00fc Ki\u015fi G\u00f6r\u00fc\u015f\u00fc<\/span><\/a><\/li>\n\t<li id=\"menu-item-4357\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4357 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/uluslararasi-patent-basvurularinin-yerel-evre-girisleri\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Uluslararas\u0131 Patent Ba\u015fvurular\u0131n\u0131n Yerel Evre Giri\u015fleri<\/span><\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/li>\n<li id=\"menu-item-4358\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-4358 item-level-0 menu-item-design-default menu-simple-dropdown item-event-hover\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/egitimler\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">E\u011fitimler<\/span><\/a>\n<div class=\"sub-menu-dropdown color-scheme-\">\n\n<div class=\"container\">\n\n<ul class=\"sub-menu color-scheme-\">\n\t<li id=\"menu-item-4360\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4360 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/firma-ici-egitim\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Firma \u0130\u00e7i E\u011fitim<\/span><\/a><\/li>\n\t<li id=\"menu-item-4359\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4359 item-level-1\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/akademisyenler-icin-dokumantasyon\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Akademisyenler \u0130\u00e7in Dok\u00fcmantasyon<\/span><\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/li>\n<li id=\"menu-item-4361\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4361 item-level-0 menu-item-design-default menu-simple-dropdown item-event-hover\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/soru-cevap\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Soru \u2013 Cevap<\/span><\/a><\/li>\n<li id=\"menu-item-4362\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-4362 item-level-0 menu-item-design-default menu-simple-dropdown item-event-hover\"><a href=\"https:\/\/www.alfapatent-stanadvoka.com\/tr\/unified-patent-court-avrupa-patent-mahkemesi\/\" class=\"woodmart-nav-link\"><span class=\"nav-link-text\">Unified Patent Court \/ Avrupa Patent Mahkemesi<\/span><\/a><\/li>\n<\/ul><\/div>\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t[vc_empty_space woodmart_hide_large=&#8221;0&#8243; woodmart_hide_medium=&#8221;0&#8243; woodmart_hide_small=&#8221;0&#8243; woodmart_hide_extra_small=&#8221;0&#8243;][\/vc_column][vc_column width=&#8221;3\/4&#8243;]\n\t\t<div id=\"wd-5fe4e75918220\" class=\"title-wrapper  woodmart-title-color-default woodmart-title-style-underlined woodmart-title-width-100 text-left woodmart-title-size-default \">\n\t\t\t\n\t\t\t<div class=\"liner-continer\">\n\t\t\t\t<span class=\"left-line\"><\/span>\n\t\t\t\t<h4 class=\"woodmart-title-container title  woodmart-font-weight-\" >Farmas\u00f6tik Sahada Patentler<\/h4>\t\t\t\t\t\t\t\t<span class=\"right-line\"><\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\n\t\t[vc_row_inner][vc_column_inner][vc_column_text text_larger=&#8221;no&#8221;]Farmas\u00f6tik bir \u00fcr\u00fcn ile alakal\u0131 bir patent istemi etkin maddeyle tek ba\u015f\u0131na veya form\u00fclasyonlar, tuzlar, \u00f6n ila\u00e7lar, izomerler ve saire ile ilgili olabilir. \u0130stemler \u00f6rne\u011fin bir \u00fcretim prosesine ili\u015fkin olabilir. Ek olarak farkl\u0131 \u00fclke mevzuatlar\u0131 alt\u0131nda kullan\u0131m istemler de form\u00fcle edilebilmektedir.<\/p>\n<p>Bir etkin madde farkl\u0131 patent ba\u015fvurular\u0131 alt\u0131nda \u00f6rne\u011fin tablet, kaps\u00fcl, merhem veya parenteral yolla verilmek \u00fczere sulu \u00e7\u00f6zelti olarak farkl\u0131 dozajlarda ve farkl\u0131 farmas\u00f6tik olarak uygun katk\u0131 maddeleri ile birlikte sunulabilir.<\/p>\n<p>Yeni veya var olan ila\u00e7lar\u0131n yeni form\u00fclasyonlar\u0131, \u00e7o\u011fu zaman dozaj ve konsantrasyon spesifikasyonlar\u0131 ana veya ba\u011f\u0131ml\u0131 istemlere dahil edilerek ve kullan\u0131m \u015fekilleri ifade edilerek koruma alt\u0131na al\u0131nabilmektedir. Kompozisyon istemleri etkin madde ile birlikte uygun ta\u015f\u0131y\u0131c\u0131 veya dolgu, ba\u011flay\u0131c\u0131, da\u011f\u0131t\u0131c\u0131 ve kayganla\u015ft\u0131r\u0131c\u0131 gibi katk\u0131 maddelerini kapsamaktad\u0131r.<\/p>\n<p>Etkin maddeler, sadece form\u00fclasyon veya kompozisyon istemleri baz\u0131nda tescil edilen patentlerin koruma kapsam\u0131na girmemektedir ve bu nedenle e\u011fer kamu mal\u0131 oldularsa ayn\u0131 maddeleri i\u00e7eren farkl\u0131 form\u00fclasyonlar veya kompozisyonlar rakip firmalar taraf\u0131ndan ticarile\u015ftirilebilir. Ancak bu t\u00fcr patentler &#8220;stratejik&#8221; davalar, yani ihlal iddias\u0131nda bulunmak ve nihai karara var\u0131lana kadar ticareti engelleyecek ge\u00e7ici ihtiyati tedbire karar verilmesini talep etmek suretiyle rekabeti azaltmak i\u00e7in kullan\u0131labilir.<\/p>\n<p>Bilinen maddeler, e\u011fer mevcut \u00fcr\u00fcnler ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda yenilik ve bulu\u015f basama\u011f\u0131na sahipse, bu maddeleri i\u00e7eren farmas\u00f6tik kompozisyonlara dair \u00fcr\u00fcn istemleri ile korunabilir. Bilhassa \u00f6nceki kullan\u0131mdan farkl\u0131 ve yeni bir kullan\u0131m \u015fekline sahip olan bir ilaca dair istem yaz\u0131labilir. \u00d6rne\u011fin egzama tedavisinde kullan\u0131lan X i\u00e7eren bir merhem, ast\u0131ma y\u00f6nelik bir ila\u00e7 olarak kullan\u0131lan X i\u00e7eren bir tabletten a\u00e7\u0131k\u00e7a farkl\u0131d\u0131r. Merhem, X daha \u00f6nce bu t\u00fcr bir form\u00fclasyonda kullan\u0131lmad\u0131\u011f\u0131 i\u00e7in yenidir ve e\u011fer X\u2019in \u00f6nceki kullan\u0131m \u015fekli harici kullan\u0131m\u0131n\u0131 akla getirmiyorsa bulu\u015f basama\u011f\u0131 mevcut olabilir.<\/p>\n<p>Bir form\u00fclasyon mesela bir ilac\u0131n kanda kontroll\u00fc sal\u0131n\u0131m\u0131 gibi belli bir etki ile ilintili olarak teknik etki sahibi olarak nitelendirilebilir. S\u00f6z konusu etkiler daha farkl\u0131 teknik etki ve faydalar alt\u0131nda tan\u0131mlanabilecek istisnai ek durumlar olmad\u0131\u011f\u0131 s\u00fcrece farmas\u00f6tik form\u00fclasyonlar konu hakk\u0131nda uzman kimsenin ortak genel bilgisi kapsam\u0131na girebilir.<\/p>\n<p>Belirtilmelidir ki ilave bir hukuk incelemesi yapmaks\u0131z\u0131n baz\u0131 yakla\u015f\u0131mlar\u0131n patentlenebilirlik kriterlerinden bulu\u015f basama\u011f\u0131na haiz olmad\u0131\u011f\u0131 do\u011frudan teslim edilebilir. Mesela form\u00fclasyon teknikleri ve farmas\u00f6tik \u00fcr\u00fcn geli\u015ftirmede kullan\u0131labilecek \u00e7e\u015fitli temel bile\u015fik gruplar\u0131 konu hakk\u0131nda uzman kimse taraf\u0131ndan bilinmektedir (pH d\u00fczenleyiciler, biyoyararlan\u0131m\u0131 artt\u0131r\u0131c\u0131 bile\u015fikler). Yine belirtmek gerekir ki tablet preparat\u0131 i\u00e7in veya s\u0131v\u0131 farmas\u00f6tik preparatlar i\u00e7in farkl\u0131 tuzlar mevzu bahis olabilir.<\/p>\n<p>Ayn\u0131 \u015fekilde farmakokinetik parametreler olarak yeni olmayan bir \u00fcr\u00fcn\u00fcn mikronizasyonu veya partik\u00fcllerin belirli bir \u00e7ap veya a\u011f\u0131rl\u0131k aral\u0131\u011f\u0131nda da\u011f\u0131l\u0131m\u0131 ile ilintili istemler yenilik a\u00e7\u0131s\u0131ndan farkl\u0131l\u0131k g\u00f6sterebilseler dahi ek teknik etkiler ve dolay\u0131s\u0131yla bulu\u015f basama\u011f\u0131 a\u00e7\u0131s\u0131ndan kriterleri kar\u015f\u0131lamaktan uzak olmaya adayd\u0131rlar. Burada dikkat edilirse sadece \u00f6nceki teknik dok\u00fcmanlar\u0131nda var olan ve yenili\u011fi veya bir ba\u015flang\u0131\u00e7 belgesi ile kombine edilerek de\u011ferlendirilmek suretiyle bulu\u015f basama\u011f\u0131n\u0131 ortadan kald\u0131ran patent referanslar\u0131na de\u011fil do\u011frudan konu hakk\u0131nda uzman kimsenin genel ortak bilgisine at\u0131f yap\u0131lmaktad\u0131r.<br \/>\n\u0130stemler tekni\u011fin bilinen durumuna dahil bulunan etkin maddelerin kombinasyonlar\u0131na ili\u015fkin olabilir. Direnci yenmek i\u00e7in ila\u00e7lar\u0131 kombine etmek farmas\u00f6tik alanda yayg\u0131n olarak kullan\u0131lan bir y\u00f6ntemdir ve konunun uzman\u0131 ki\u015fi i\u00e7in a\u015fikard\u0131r. Kombinasyon yeni ve bulu\u015f basama\u011f\u0131na sahip sinerjik bir etki yaratmal\u0131d\u0131r. S\u00f6z konusu sinerjik etki istemlerin koruma alan\u0131na dahil, tarifnamede uygun olarak a\u00e7\u0131klanm\u0131\u015f ve kan\u0131tlanm\u0131\u015f (\u00f6rne\u011fin biyolojik testlere dayanarak) ve dolay\u0131s\u0131yla bulu\u015f basama\u011f\u0131 ile ili\u015fkilendirilmi\u015f olmal\u0131d\u0131r. \u0130ki veya daha fazla kompozisyon aras\u0131ndaki etkile\u015fimin v\u00fccut i\u00e7erisinde ger\u00e7ekle\u015fmesi bulu\u015f niteli\u011finden yoksun kabul edilmesine yol a\u00e7abilir. Bir ba\u015fka deyi\u015fle s\u00f6z konusu sinerjik etkinlik bulu\u015f kapsam\u0131nda de\u011fil klinik ara\u015ft\u0131rmalar sonucu ke\u015ffedilmi\u015ftir.<\/p>\n<p>Bilinen ila\u00e7lar\u0131n kombinasyonunun hastaya verilme metodu tipik olarak Avrupa Patent S\u00f6zle\u015fmesi alt\u0131nda patentlenebilirlikten muaf kabul edilmektedir.<\/p>\n<p>Tekni\u011fin bilinen durumuna dahil bir \u00fcr\u00fcn\u00fcn hastalara verilme dozaj\u0131n\u0131 kapsayan istemler s\u00f6z konusu bulundu\u011funda bu istemler birer \u00fcr\u00fcn istemi olarak yaz\u0131lm\u0131\u015f olsalar da, kapsad\u0131klar\u0131 alan bir \u00fcr\u00fcn veya proses de\u011fil bir \u00fcr\u00fcn\u00fcn terap\u00f6tik olarak kullan\u0131m y\u00f6ntemi oldu\u011fu i\u00e7in bu istemler t\u0131bbi tedavi y\u00f6ntemlerine dair istemler ile ayn\u0131 etkiye sahiptir. Dozaj de\u011fi\u015fikli\u011fi teknik etki yerine v\u00fccut \u00fczerinde etki \u00fcretti\u011finden sanayiye uygulanabilirlik a\u00e7\u0131s\u0131ndan de\u011ferlendirilmelidir.<\/p>\n<p>Farmas\u00f6tik patentler tekni\u011fin bilinen durumu kapsam\u0131ndaki etkin maddelerin yeni tuzlar\u0131n\u0131 koruma kapsam\u0131na almay\u0131 hedefleyebilir. Tuzlar tipik olarak bir ilac\u0131n stabilitesini veya \u00e7\u00f6z\u00fcn\u00fcrl\u00fc\u011f\u00fcn\u00fcn artt\u0131rmak i\u00e7in kullan\u0131lmakta olup farkl\u0131 \u00e7\u00f6z\u00fcn\u00fcrl\u00fck ve dolay\u0131s\u0131yla farkl\u0131 biyoyararlan\u0131m \u00f6zelli\u011fine sahip olduklar\u0131 farmas\u00f6tik alanda yayg\u0131n olarak bilindi\u011finden etkin madde asit veya baz ise bu maddenin tuzunu elde etmek konu hakk\u0131nda uzman olmayan uygulamac\u0131lar i\u00e7in bile genel fizikokimyasal \u00f6zellikler hakk\u0131nda tahminde bulunabilmek a\u00e7\u0131s\u0131ndan a\u015fikar kabul edilebilmektedir. S\u00f6z konusu proseslerin kimi zorluklar i\u00e7ermesi bulu\u015f basama\u011f\u0131 iddias\u0131nda bulunmak i\u00e7in yeterli sebep de\u011fildir.<\/p>\n<p>Terap\u00f6tik aktivitesi olan baz\u0131 etkin maddelerin polimorfik formlar\u0131, yani bir ba\u015fka ifade ile amorf ve\/veya de\u011fi\u015fik kristal yap\u0131lar halinde de\u011fi\u015fik fiziksel formlar\u0131 olabilir ve bu formlar\u0131n farmas\u00f6tik olarak \u00f6nemli olacak \u00e7\u00f6z\u00fcn\u00fcrl\u00fck ve dolay\u0131s\u0131yla biyoyararlan\u0131m gibi kimi \u00f6zellikler bak\u0131m\u0131ndan farkl\u0131l\u0131klar\u0131 olabilir. Polimorfizm do\u011fal bir \u00f6zellik olup ila\u00e7 form\u00fclasyonu ara\u015ft\u0131rmalar\u0131nda kullan\u0131lan rutin deneyler sonucu bulunan polimorflar yarat\u0131lamayacak veya bir bulu\u015f konusu olarak icat edilemeyecek yap\u0131lard\u0131r.<\/p>\n<p>Birbirinin yans\u0131mas\u0131 gibi davranan enantiyomerler (optik izomerler) organik kimyada, d\u00f6rt farkl\u0131 s\u00fcbstit\u00fcent ba\u011fl\u0131 karbon atomu i\u00e7eren bile\u015fiklerde g\u00f6r\u00fclmekte olup enantiyomerlerin bu \u00f6zelli\u011fi patent alan\u0131nda ilk patentten s\u00fcresi bittikten sonra da yararlanmaya devam edebilmek i\u00e7in ilk \u00f6nce &#8220;rasemik&#8221; kar\u0131\u015f\u0131m\u0131 koruma alt\u0131na al\u0131p daha sonra en etkin enantiyomer \u00fczerinde hak talep etmek suretiyle ba\u015fvuru konusu yap\u0131labilmektedir. \u0130zole edilmi\u015f bir enantiyomerin rasemik kar\u0131\u015f\u0131ma g\u00f6re daha etkin olup olmad\u0131\u011f\u0131n\u0131 test etmek rutin bir y\u00f6ntem olup en az bir enantiyomerin rasemik kar\u0131\u015f\u0131ma g\u00f6re daha etkin olmas\u0131 beklenmektedir. Enantiyomere sahip bir bile\u015fi\u011fin kimyasal form\u00fcl\u00fc a\u00e7\u0131kland\u0131\u011f\u0131nda, form\u00fcl enantiyomerin varl\u0131\u011f\u0131n\u0131 ortaya koydu\u011fundan bu enantiyomer yenilik \u00f6zelli\u011fini kaybeder.<\/p>\n<p>Kimi durumlarda farmas\u00f6tik bile\u015fikler v\u00fccut i\u00e7inde metabolize olarak bir aktif metabolit olu\u015fturur. Metabolitler etkin maddenin v\u00fccut i\u00e7inde olu\u015fturulan t\u00fcrevleridir ve &#8216;yarat\u0131lm\u0131\u015f&#8217; veya &#8216;icat edilmi\u015f&#8217; olarak g\u00f6r\u00fclemezler.<\/p>\n<h4>T\u00dcRK\u0130YE\u2019DE \u0130LA\u00c7 PATENTLER\u0130N\u0130N HUKUK\u0130 DURUMU<\/h4>\n<p>T\u00fcrkiye\u2019deki ilk patent yasas\u0131 olan 1879 tarihli \u0130htira Berat\u0131 kanunu gere\u011fince 1995 y\u0131l\u0131na kadar ila\u00e7 patenti ba\u015fvurular\u0131 i\u015fleme al\u0131nmam\u0131\u015ft\u0131r. TRIPS Anla\u015fmas\u0131\u2019n\u0131n 70\u2019inci maddesinin 8\u2019inci bendinde yer alan h\u00fck\u00fcm uyar\u0131nca, daha \u00f6nce ila\u00e7lara patent vermeyen b\u00fct\u00fcn \u00fclkelere, t\u0131bbi ve zirai ila\u00e7lar\u0131n patent ile korunmas\u0131 i\u00e7in bu konulardaki patent ba\u015fvurular\u0131n\u0131 i\u015fleme alma mecburiyeti getirilmi\u015ftir.<\/p>\n<p>T\u00fcrkiye\u2019de 27.06.1995 tarihinde kabul edilen Patentlerin Korunmas\u0131 Hakk\u0131ndaki 551 Say\u0131l\u0131 Kanun H\u00fckm\u00fcnde Kararname h\u00fck\u00fcmlerine g\u00f6re patent korumas\u0131 i\u00e7in ba\u015fvurular 1 Ocak 1995 tarihinden itibaren i\u015fleme al\u0131nmaya ve incelenmeye ba\u015flanm\u0131\u015ft\u0131r, ancak koruma fiili olarak 1 Ocak 1999\u2019dan sonra olmu\u015ftur.<\/p>\n<h4>\u0130LA\u00c7 PATENT\u0130 T\u0130PLER\u0130<\/h4>\n<p>\u0130la\u00e7larla ilgili olarak al\u0131nabilecek patentler de\u011ferlendirilecek olursa \u015f\u00f6yle s\u0131ralanabilir:<\/p>\n<p>-Yeni molek\u00fcllerin elde edilmesiyle ilgili olan molek\u00fcl (\u00fcr\u00fcn) patenti<br \/>\n-Molek\u00fcllerin kristal yap\u0131s\u0131yla ilgili olan polimorf patenti<br \/>\n-Birka\u00e7 etken maddenin ayn\u0131 form\u00fclasyonda bir arada kullan\u0131lmas\u0131yla ilgili olan kombinasyon patenti<br \/>\n-Etken ve yard\u0131mc\u0131 maddelerden olu\u015fan \u00fcr\u00fcn\u00fcn i\u00e7eri\u011fi, dozaj formu ile ilgili olan form\u00fclasyon patenti<br \/>\n-Molek\u00fcl\u00fcn t\u0131bbi kullan\u0131m alan\u0131yla ilgili olan endikasyon patenti<br \/>\n-Bir \u00fcr\u00fcn\u00fcn veya dozaj formunun \u00fcretilmesi i\u00e7in kullan\u0131lan y\u00f6ntemle ilgili olan proses (usul) patenti<\/p>\n<p>\u0130la\u00e7larla ilgili as\u0131l patent genelde molek\u00fcl patenti olup, o etken maddenin 20 y\u0131l boyunca\u00a0 \u00fcretilememesini ve kullan\u0131lamamas\u0131n\u0131 sa\u011flar.<\/p>\n<p>Endikasyon ile ilgili bulu\u015flar ise herhangi bir etken maddenin v\u00fccuda daha \u00f6nce bilinmeyen etkileriyle ilgili olup bir ilac\u0131n ikinci ya da \u00fc\u00e7\u00fcnc\u00fc kullan\u0131m amac\u0131n\u0131n patentle korunmas\u0131 anlam\u0131na gelmektedir.<\/p>\n<p>Usul patentlerinde koruma kapsam\u0131 di\u011fer patentlerden farkl\u0131d\u0131r. Herhangi bir \u00fcr\u00fcn\u00fcn \u00fcretilmesi i\u00e7in uygulanan proseste kullan\u0131lan usul patenti uyguland\u0131\u011f\u0131 \u00fcr\u00fcn patentli oldu\u011fu s\u00fcrece kullan\u0131lamaz.<\/p>\n<p>As\u0131l patenti -bulu\u015fun t\u00fcm \u00f6zelliklerini ta\u015f\u0131yan, bulu\u015fun kendisi i\u00e7in verilmi\u015f ana patent- bitmi\u015f ama herhangi bir usul patenti olan bir ilac\u0131, usul patentine tecav\u00fcz edilmeden farkl\u0131 y\u00f6ntemler kullanarak \u00fcretmek, kullanmak ve satmak m\u00fcmk\u00fcnd\u00fcr. Yani, usul patentlerini farkl\u0131 yollarla a\u015fmak m\u00fcmk\u00fcn olabilmektedir.<\/p>\n<p>TRIPS antla\u015fmas\u0131na g\u00f6re, \u00fcr\u00fcn ve usul patentleri aras\u0131ndaki bu farkl\u0131l\u0131k g\u00f6z \u00f6n\u00fcne al\u0131narak etken maddenin patent korumas\u0131na al\u0131nmas\u0131n\u0131 geciktirmek amac\u0131yla, uygulamaya yeni ba\u015flayacak olan \u00fclkelerde \u00fcr\u00fcn patentleri i\u00e7in ge\u00e7i\u015f s\u00fcresinin 5 y\u0131l daha ge\u00e7 olmas\u0131 \u00f6ng\u00f6r\u00fclm\u00fc\u015ft\u00fcr.<\/p>\n<h4>AVRUPA PATENT S\u00d6ZLE\u015eMES\u0130 BA\u011eLAMINDA END\u0130KASYON \u0130STEMLER\u0130<\/h4>\n<p>A\u015fa\u011f\u0131da Avrupa Patent S\u00f6zle\u015fmesi Md. 54(3) ve 54(4) h\u00fck\u00fcmleri verilmektedir:<\/p>\n<p>(3)<br \/>\nParagraphs 2 and 3 shall not exclude the patentability of any substance or composition, comprised in the state of the art, for use in a method referred to in Article 53(c), provided that its use for any such method is not comprised in the state of the art.<\/p>\n<p>(4)<br \/>\nParagraphs 2 and 3 shall also not exclude the patentability of any substance or composition referred to in paragraph 4 for any specific use in a method referred to in Article 53(c), provided that such use is not comprised in the state of the art.<\/p>\n<p>Buna g\u00f6re EPC \u00fczerinden Avrupa\u2019da merkezi olarak tescil olan ve T\u00fcrkiye\u2019de valide edilen Avrupa patentlerinin fasik\u00fcl yay\u0131nlar\u0131 endikasyon istemi i\u00e7eren tarifnamelere sahip olabilirken ayn\u0131 durum do\u011frudan yap\u0131lan T\u00fcrk patent ba\u015fvurular\u0131 ve PCT alt\u0131nda \u00fclkemize giri\u015f yapan patent ba\u015fvurular\u0131 i\u00e7in ge\u00e7erli de\u011fildir.<\/p>\n<h4>\u0130LA\u00c7TA EK PATENT S\u00dcRES\u0130<\/h4>\n<p>\u0130la\u00e7lar i\u00e7in patent a\u015famas\u0131ndan sonra bir de deney a\u015famas\u0131 ve ruhsat a\u015famas\u0131 s\u00f6z konusu oldu\u011fu i\u00e7in patent alm\u0131\u015f bir ila\u00e7 etken maddesi patentin al\u0131nd\u0131\u011f\u0131 an pazara s\u00fcr\u00fclemez. Bu s\u0131rada kaybedilen s\u00fcre, kanunun patent sahibine verdi\u011fi 20 y\u0131ll\u0131k tekel hakk\u0131n\u0131 fiilen azalt\u0131r. Ek patent s\u00fcresi patent sahibinin alm\u0131\u015f oldu\u011fu patentten bir s\u00fcre daha yararlanmas\u0131n\u0131 sa\u011flayan, \u00f6zellikle innovat\u00f6r firmalar a\u00e7\u0131s\u0131ndan tercih edilen bir uygulamad\u0131r.<\/p>\n<p>Bug\u00fcn Avrupa Birli\u011fi\u2019nde \u201cSupplementary Protection Certificate for Medicinal Products &#8211; T\u0131bbi \u00dcr\u00fcnler \u0130\u00e7in Ek Koruma Belgesi\u201d ad\u0131 verilen bu uygulamaya g\u00f6re, patentle korunan ila\u00e7larda patent s\u00fcresinin ba\u015fvuru tarihinden itibaren 20 y\u0131l yerine en fazla 25 y\u0131l veya ruhsat al\u0131nd\u0131ktan itibaren 15 y\u0131l olarak kabul edilmesi \u00f6ng\u00f6r\u00fclm\u00fc\u015ft\u00fcr. B\u00f6ylece patentli ila\u00e7larda koruma s\u00fcresi en fazla 5 y\u0131l kadar uzat\u0131lm\u0131\u015f olmaktad\u0131r. Bu uygulamaya k\u0131saca \u201cila\u00e7 patentlerine ek koruma uygulamas\u0131\u201d ad\u0131 verilmektedir.<\/p>\n<p>Bu koruma s\u00fcresi sadece farmas\u00f6tik \u00fcr\u00fcnler ve zirai ila\u00e7lar i\u00e7in ge\u00e7erli olup patent s\u00fcresi bitti\u011finde y\u00fcr\u00fcrl\u00fc\u011fe girer. T\u00fcrkiye\u2019de bu belge uygulanmamaktad\u0131r.<\/p>\n<h4>BOLAR \u0130ST\u0130SNASI<\/h4>\n<p>Bolar ististas\u0131, orjinal ilac\u0131n patent s\u00fcresi hen\u00fcz dolmadan jenerik ila\u00e7 \u00fcreticilerine \u00e7al\u0131\u015fmalara ba\u015flama hakk\u0131 sa\u011flayan bir kanundur. Bu imtiyaz\u0131n ard\u0131ndaki fikir jenerik ila\u00e7 \u00fcreten firmalar\u0131n patent s\u00fcresi dolan ila\u00e7lar i\u00e7in zaman kaybetmeden pazara girebilmeleridir.<\/p>\n<h4>VER\u0130 \u0130MT\u0130YAZI<\/h4>\n<p>Veri koruma uygulamas\u0131 e\u015fde\u011fer ila\u00e7larla yak\u0131ndan ilgili bir konu olup k\u0131salt\u0131lm\u0131\u015f ruhsat ba\u015fvurusu yap\u0131lmad\u0131\u011f\u0131 s\u00fcrece ruhsat almak i\u00e7in t\u00fcm farmas\u00f6tik verilerin (toksikolojik ve farmakolojik testler ve klinik ara\u015ft\u0131rma sonu\u00e7lar\u0131) Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131\u2019na sunulmas\u0131 gerekir.<\/p>\n<p>Jenerik ila\u00e7 \u00fcreticisi firmalar k\u0131salt\u0131lm\u0131\u015f ba\u015fvuruda bulunurken ilac\u0131n etkinli\u011fi ve g\u00fcvenli\u011fini g\u00f6steren orijinal ilaca ait klinik \u00f6ncesi ve klinik test sonu\u00e7lar\u0131n\u0131 referans g\u00f6sterirler. Veri korunmas\u0131 hakk\u0131, yetkili makamlar\u0131n e\u015fde\u011fer ila\u00e7lara onay verirken, belli bir s\u00fcre i\u00e7in orijinal ilaca ait klinik \u00f6ncesi ve klinik test verilerinin referans olarak kabul edilmesini engellemektedir. Bu anlamda veri korumas\u0131, ruhsat verecek makama ibraz edilen gizli bilgilerin korunmas\u0131n\u0131 ve bunlara \u00fc\u00e7\u00fcnc\u00fc ki\u015filerin at\u0131fta bulunamamas\u0131n\u0131 sa\u011flar.<\/p>\n<p>Ruhsatland\u0131rma Y\u00f6netmeli\u011fi, Madde 9\/3 k\u0131salt\u0131lm\u0131\u015f ba\u015fvuru:<\/p>\n<p>\u201cT\u0131bbi \u00fcr\u00fcn\u00fcn, y\u00fcr\u00fcrl\u00fckteki mevzuat h\u00fck\u00fcmleri uyar\u0131nca ruhsatland\u0131r\u0131lm\u0131\u015f ve veri imtiyaz\u0131 s\u00fcresini doldurmu\u015f bir t\u0131bbi \u00fcr\u00fcne temelde benzer olmas\u0131. Bu alt bent ile h\u00fckme ba\u011flanan veri imtiyaz\u0131 s\u00fcresi, G\u00fcmr\u00fck Birli\u011fi Alan\u0131nda yer alan \u00fclkelerden birinde 1\/1\/2001 tarihinden sonra ilk defa ruhsatland\u0131r\u0131lm\u0131\u015f orijinal \u00fcr\u00fcnlerden 1\/1\/2005 tarihine kadar T\u00fcrkiye\u2019de herhangi bir jenerik ruhsat ba\u015fvurusu yap\u0131lmam\u0131\u015f olanlar ile G\u00fcmr\u00fck Birli\u011fi Alan\u0131nda yer alan \u00fclkelerden birinde 1\/1\/2005 tarihinden sonra ilk defa ruhsatland\u0131r\u0131lacak orijinal \u00fcr\u00fcnler a\u00e7\u0131s\u0131ndan ge\u00e7erli olup, G\u00fcmr\u00fck Birli\u011fi Alan\u0131nda ilk defa ruhsatland\u0131r\u0131ld\u0131\u011f\u0131 tarihten ba\u015flayarak molek\u00fcl\u00fcn T\u00fcrkiye&#8217;deki patent s\u00fcresi ile s\u0131n\u0131rl\u0131 olmak \u00fczere 6 (alt\u0131) y\u0131ld\u0131r. Bununla birlikte, piyasaya s\u00fcr\u00fclm\u00fc\u015f t\u0131bbi \u00fcr\u00fcnlerden farkl\u0131 terap\u00f6tik endikasyon, farkl\u0131 kullan\u0131m yolu, farkl\u0131 doz uygulanmas\u0131n\u0131n \u00f6ng\u00f6r\u00fclmesi halinde, buna y\u00f6nelik yap\u0131lm\u0131\u015f klinik ara\u015ft\u0131rmalar\u0131n sonu\u00e7lar\u0131 ve e\u011fer gerekli ise toksikolojik, farmakolojik \u00e7al\u0131\u015fmalar\u0131n sonu\u00e7lar\u0131n\u0131n sa\u011flanmas\u0131 zorunludur.\u201d<\/p>\n<p>Sonu\u00e7 olarak, jenerik \u00fcretici firmalar orijinal firman\u0131n ruhsat ald\u0131\u011f\u0131 tarihten ba\u015flayarak 6 y\u0131l s\u00fcresince s\u00f6z konusu ila\u00e7 i\u00e7in ruhsat ba\u015fvurusu yapmamaktad\u0131rlar.<\/p>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1608724517525{margin-bottom: 0px !important;padding-bottom: 0px !important;}&#8221; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243; woodmart_gradient_switch=&#8221;no&#8221; row_reverse_mobile=&#8221;0&#8243; row_reverse_tablet=&#8221;0&#8243; woodmart_disable_overflow=&#8221;0&#8243;][vc_column][vc_column_text text_larger=&#8221;no&#8221;][vc_row full_width=\"stretch_row\" gap=\"35\" css=\".vc_custom_1608557031429{margin-bottom: 0px !important;padding-bottom: 0px !important;background: #727272 url(http:\/\/www.alfapatent-stanadvoka.com\/wp-content\/uploads\/2020\/12\/bg-footer.jpg?id=3208) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}\" mobile_bg_img_hidden=\"no\" tablet_bg_img_hidden=\"no\" woodmart_parallax=\"0\" woodmart_gradient_switch=\"no\" row_reverse_mobile=\"0\" row_reverse_tablet=\"0\" woodmart_disable_overflow=\"0\"][vc_column]\t\t\t<div id=\"carousel-352\" class=\"woodmart-carousel-container info-box-carousel-wrapper  scroll-init woodmart-carousel-spacing-10\" data-owl-carousel data-hide_pagination_control=\"yes\" data-hide_prev_next_buttons=\"no\" data-dragEndSpeed=\"600\" data-desktop=\"4\" data-tablet_landscape=\"4\" data-tablet=\"3\" data-mobile=\"1\">\n\t\t\t\t<div class=\"owl-carousel info-box-carousel  owl-items-lg-4 owl-items-md-4 owl-items-sm-3 owl-items-xs-1\" >\n\t\t\t\t\t\t\t\t<div class=\"info-box-wrapper \">\n\t\t\t\t<div id=\"wd-5ff372606800e\" class=\" woodmart-info-box text-center box-icon-align-top box-style-shadow color-scheme- woodmart-bg-none box-title-custom with-btn box-btn-static \"  >\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"box-icon-wrapper  box-with-icon box-icon-simple\">\n\t\t\t\t\t\t\t<div class=\"info-box-icon\">\n\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"info-icon image-1 \" src=\"https:\/\/www.alfapatent-stanadvoka.com\/wp-content\/uploads\/2020\/12\/1-17-300x100.jpg\" width=\"300\" height=\"100\" alt=\"1-17\" title=\"1-17\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<div class=\"info-box-content\">\n\t\t\t\t\t\t<p class=\"info-box-title woodmart-font-weight-500 box-title-style-default font-alt\">Firma \u0130\u00e7i E\u011fitimler<\/p>\t\t\t\t\t\t<div class=\"info-box-inner reset-mb-10\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<div class=\"info-btn-wrapper\"><div id=\"wd-6a0586dc3bfb1\" class=\"woodmart-button-wrapper text-center\"><a href=\"http:\/\/www.alfapatent-stanadvoka.com\/tr\/firma-ici-egitim\/\" title=\"#s\" class=\"btn btn-color-primary btn-style-default btn-shape-rectangle btn-size-extra-small\">G\u00f6r\u00fcnt\u00fcle<\/a><\/div><\/div>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<style><\/style>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<div class=\"info-box-wrapper \">\n\t\t\t\t<div id=\"wd-5fea117ceb8cd\" class=\" woodmart-info-box text-center box-icon-align-top box-style-shadow color-scheme- woodmart-bg-none box-title-custom with-btn box-btn-static \"  >\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"box-icon-wrapper  box-with-icon box-icon-simple\">\n\t\t\t\t\t\t\t<div class=\"info-box-icon\">\n\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"info-icon image-1 \" src=\"https:\/\/www.alfapatent-stanadvoka.com\/wp-content\/uploads\/2020\/12\/1-21-300x100.jpg\" width=\"300\" height=\"100\" alt=\"1-21\" title=\"1-21\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<div class=\"info-box-content\">\n\t\t\t\t\t\t<p class=\"info-box-title woodmart-font-weight-500 box-title-style-default font-alt\">Ad\u0131m Ad\u0131m Patent Ba\u015fvurusu<\/p>\t\t\t\t\t\t<div class=\"info-box-inner reset-mb-10\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<div class=\"info-btn-wrapper\"><div id=\"wd-6a0586dc3d0c4\" class=\"woodmart-button-wrapper text-center\"><a href=\"http:\/\/www.alfapatent-stanadvoka.com\/tr\/adim-adim-patent-basvurusu\/\" title=\"#sw\" class=\"btn btn-color-primary btn-style-default btn-shape-rectangle btn-size-extra-small\">G\u00f6r\u00fcnt\u00fcle<\/a><\/div><\/div>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<style><\/style>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<div class=\"info-box-wrapper \">\n\t\t\t\t<div id=\"wd-5fea1182aeda3\" class=\" woodmart-info-box text-center box-icon-align-top box-style-shadow color-scheme- woodmart-bg-none box-title-custom with-btn box-btn-static \"  >\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"box-icon-wrapper  box-with-icon box-icon-simple\">\n\t\t\t\t\t\t\t<div class=\"info-box-icon\">\n\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"info-icon image-1 \" src=\"https:\/\/www.alfapatent-stanadvoka.com\/wp-content\/uploads\/2020\/12\/1-20-300x100.jpg\" width=\"300\" height=\"100\" alt=\"1-20\" title=\"1-20\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<div class=\"info-box-content\">\n\t\t\t\t\t\t<p class=\"info-box-title woodmart-font-weight-500 box-title-style-default font-alt\">Patent Te\u015fvikleri<\/p>\t\t\t\t\t\t<div class=\"info-box-inner reset-mb-10\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<div class=\"info-btn-wrapper\"><div id=\"wd-6a0586dc3e328\" class=\"woodmart-button-wrapper text-center\"><a href=\"http:\/\/www.alfapatent-stanadvoka.com\/tr\/patent-tesvikleri\/\" title=\"#sw\" class=\"btn btn-color-primary btn-style-default btn-shape-rectangle btn-size-extra-small\">G\u00f6r\u00fcnt\u00fcle<\/a><\/div><\/div>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<style><\/style>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<div class=\"info-box-wrapper \">\n\t\t\t\t<div id=\"wd-5fea118790855\" class=\" woodmart-info-box text-center box-icon-align-top box-style-shadow color-scheme- woodmart-bg-none box-title-custom with-btn box-btn-static \"  >\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"box-icon-wrapper  box-with-icon box-icon-simple\">\n\t\t\t\t\t\t\t<div class=\"info-box-icon\">\n\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"info-icon image-1 \" src=\"https:\/\/www.alfapatent-stanadvoka.com\/wp-content\/uploads\/2020\/12\/1-19-300x100.jpg\" width=\"300\" height=\"100\" alt=\"1-19\" title=\"1-19\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<div class=\"info-box-content\">\n\t\t\t\t\t\t<p class=\"info-box-title woodmart-font-weight-500 box-title-style-default font-alt\">Hukuki \u0130htilaflar<\/p>\t\t\t\t\t\t<div class=\"info-box-inner reset-mb-10\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<div class=\"info-btn-wrapper\"><div id=\"wd-6a0586dc3f52c\" class=\"woodmart-button-wrapper text-center\"><a href=\"http:\/\/www.alfapatent-stanadvoka.com\/tr\/hukuki-ihtilaflar\/\" title=\"#sw\" class=\"btn btn-color-primary btn-style-default btn-shape-rectangle btn-size-extra-small\">G\u00f6r\u00fcnt\u00fcle<\/a><\/div><\/div>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<style><\/style>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t[\/vc_column][\/vc_row]<style data-type=\"vc_shortcodes-custom-css\">.vc_custom_1608557031429{margin-bottom: 0px !important;padding-bottom: 0px !important;background: #727272 url(http:\/\/www.alfapatent-stanadvoka.com\/wp-content\/uploads\/2020\/12\/bg-footer.jpg?id=3208) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}#wd-5ff372606800e .info-box-title{font-size:14px;line-height:16px;color:#2b2b2b;}#wd-5fea117ceb8cd .info-box-title{font-size:14px;line-height:16px;color:#2b2b2b;}#wd-5fea1182aeda3 .info-box-title{font-size:14px;line-height:16px;color:#2b2b2b;}#wd-5fea118790855 .info-box-title{font-size:14px;line-height:16px;color:#2b2b2b;}<\/style>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;1\/4&#8243; offset=&#8221;vc_hidden-md vc_hidden-sm vc_hidden-xs&#8221; mobile_bg_img_hidden=&#8221;no&#8221; tablet_bg_img_hidden=&#8221;no&#8221; woodmart_parallax=&#8221;0&#8243; woodmart_sticky_column=&#8221;false&#8221; parallax_scroll=&#8221;no&#8221; mobile_reset_margin=&#8221;no&#8221; tablet_reset_margin=&#8221;no&#8221;][vc_empty_space woodmart_hide_large=&#8221;0&#8243; woodmart_hide_medium=&#8221;0&#8243; woodmart_hide_small=&#8221;0&#8243; woodmart_hide_extra_small=&#8221;0&#8243;][\/vc_column][vc_column width=&#8221;3\/4&#8243;][vc_row_inner][vc_column_inner][vc_column_text text_larger=&#8221;no&#8221;]Farmas\u00f6tik bir \u00fcr\u00fcn<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4277","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/pages\/4277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/comments?post=4277"}],"version-history":[{"count":5,"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/pages\/4277\/revisions"}],"predecessor-version":[{"id":4979,"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/pages\/4277\/revisions\/4979"}],"wp:attachment":[{"href":"https:\/\/www.alfapatent-stanadvoka.com\/tr\/wp-json\/wp\/v2\/media?parent=4277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}